Literature DB >> 23643309

Prominent fatigue in spinal muscular atrophy and spinal and bulbar muscular atrophy: evidence of activity-dependent conduction block.

Yu-ichi Noto1, Sonoko Misawa, Masahiro Mori, Naoki Kawaguchi, Kazuaki Kanai, Kazumoto Shibuya, Sagiri Isose, Saiko Nasu, Yukari Sekiguchi, Minako Beppu, Shigeki Ohmori, Masanori Nakagawa, Satoshi Kuwabara.   

Abstract

OBJECTIVES: To clarify whether patients with spinal muscular atrophy (SMA) or spinal and bulbar muscular atrophy (SBMA) suffer disabling muscle fatigue, and whether activity-dependent conduction block (ADCB) contributes to their fatigue. ADCB is usually caused by reduced safety factor for impulse transmission in demyelinating diseases, whereas markedly increased axonal branching associated with collateral sprouting may reduce the safety factor in chronic lower motor neuron disorders.
METHODS: We assessed the fatigue severity scale (FSS) in 22 patients with SMA/SBMA, and in 100 disease controls (multiple sclerosis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy (CIDP), and axonal neuropathy). We then performed stimulated-single fibre electromyography (s-SFEMG) in the extensor digitorum communis (EDC) muscle of 21 SMA/SBMA patients, 6 CIDP patients, and 10 normal subjects.
RESULTS: The FSS score was the highest in SMA/SBMA patients [4.9 ± 1.1 (mean ± SD)], with 81% of them complaining of disabling fatigue, compared with normal controls (3.5 ± 1.0), whereas patients with multiple sclerosis (4.3 ± 1.6), myasthenia gravis (4.0 ± 1.6) or CIDP (4.3 ± 1.4) also showed higher FSS score. When 2000 stimuli were delivered at 20 Hz in s-SFEMG, conduction block of single motor axons developed in 46% of patients with SMA/SBMA, and 40% of CIDP patients, but in none of the normal controls.
CONCLUSION: SMA/SBMA patients frequently suffer from disabling fatigue presumably caused by ADCB induced by voluntary activity. SIGNIFICANCE: ADCB could be the mechanism for muscle fatigue in chronic lower motor neuron diseases.
Copyright © 2013 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Activity-dependent conduction block; Chronic inflammatory demyelinating polyneuropathy; Fatigue; Spinal and bulbar muscular atrophy; Spinal muscular atrophy; Stimulated-single fiber electromyography

Mesh:

Year:  2013        PMID: 23643309     DOI: 10.1016/j.clinph.2012.12.053

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  10 in total

1.  Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy.

Authors:  Kentaro Oki; Katherine Halievski; Laura Vicente; Youfen Xu; Donald Zeolla; Jessica Poort; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; Robert W Wiseman; S Marc Breedlove; Cynthia L Jordan
Journal:  J Appl Physiol (1985)       Date:  2015-02-05

2.  Acetylcholinesterase inhibitor responsive myasthenia in a Filipino male with X-linked recessive spinal and bulbar muscular atrophy.

Authors:  Roland Dominic G Jamora; Mario B Prado; Carlos L Chua
Journal:  Neurol Sci       Date:  2021-06-03       Impact factor: 3.307

3.  Fatigue in adults with spinal muscular atrophy under treatment with nusinersen.

Authors:  K Kizina; B Stolte; A Totzeck; S Bolz; M Schlag; C Ose; O von Velsen; C Kleinschnitz; Tim Hagenacker
Journal:  Sci Rep       Date:  2020-07-06       Impact factor: 4.379

4.  Muscle contractility in spinobulbar muscular atrophy.

Authors:  Julia R Dahlqvist; Sofie T Oestergaard; Nanna S Poulsen; Kirsten Lykke Knak; Carsten Thomsen; John Vissing
Journal:  Sci Rep       Date:  2019-03-18       Impact factor: 4.379

5.  Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests.

Authors:  Bart Bartels; Laura E Habets; Marloes Stam; Renske I Wadman; Camiel A Wijngaarde; Marja A G C Schoenmakers; Tim Takken; Erik H J Hulzebos; W Ludo van der Pol; Janke F de Groot
Journal:  BMC Neurol       Date:  2019-02-09       Impact factor: 2.474

6.  The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

Authors:  Pierre-François Pradat; Emilien Bernard; Philippe Corcia; Philippe Couratier; Christel Jublanc; Giorgia Querin; Capucine Morélot Panzini; François Salachas; Christophe Vial; Karim Wahbi; Peter Bede; Claude Desnuelle
Journal:  Orphanet J Rare Dis       Date:  2020-04-10       Impact factor: 4.123

7.  Possible implication of undescribed SMN1-SMN2 genotype in chronic EMG-pattern of SMA with transitory acute denervation.

Authors:  Girolamo A Vitello; Francesco Calì; Mirella Vinci; Carmela Scuderi; Francesca L'Episcopo; Antonino Musumeci; Sebastiano A Musumeci; Antonio G Nicotera
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-12-01       Impact factor: 2.041

8.  Fatigue and activity-dependent conduction block in neuromuscular disorders.

Authors:  Atsuko Tsuneyama; Kazumoto Shibuya; Sonoko Misawa; Yo-Ichi Suzuki; Tomoki Suichi; Yuta Kojima; Keigo Nakamura; Hiroki Kano; Mario J Prado; Satoshi Kuwabara
Journal:  Clin Neurophysiol Pract       Date:  2022-03-02

9.  Quantitative description of upper extremity function and activity of people with spinal muscular atrophy.

Authors:  Mariska M H P Janssen; Laura H C Peeters; Imelda J M de Groot
Journal:  J Neuroeng Rehabil       Date:  2020-09-11       Impact factor: 4.262

10.  An observational cohort study on impact, dimensions and outcome of perceived fatigue in adult 5q-spinal muscular atrophy patients receiving nusinersen treatment.

Authors:  Camilla Binz; Olivia Schreiber-Katz; Susanne Petri; Alma Osmanovic; Mareike Kumpe; Gresa Ranxha; Hannah Siegler; Gary Wieselmann
Journal:  J Neurol       Date:  2020-10-07       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.